Synonyms: Cleviprex®
clevidipine is an approved drug (FDA (2008))
Compound class:
Synthetic organic
Comment: Clevidipine is a dihydropyridine class L-type calcium channel blocker, whic is highly selective for vascular smooth muscle over myocardial smooth muscle.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2008)) |
Approved drug? | Yes. FDA (2008) |
IUPAC Name ![]() |
O3-(butanoyloxymethyl) O5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
International Nonproprietary Names ![]() |
|
INN number | INN |
7490 | clevidipine |
Synonyms ![]() |
Cleviprex® |
Database Links ![]() |
|
CAS Registry No. | 167221-71-8 |
ChEMBL Ligand | CHEMBL1237132 |
DrugBank Ligand | DB04920 |
DrugCentral Ligand | 674 |
GtoPdb PubChem SID | 187051771 |
PubChem CID | 153994 |
Search Google for chemical match using the InChIKey | KPBZROQVTHLCDU-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | KPBZROQVTHLCDU |
Search PubMed clinical trials | clevidipine |
Search PubMed titles | clevidipine |
Search PubMed titles/abstracts | clevidipine |
UniChem Compound Search for chemical match using the InChIKey | KPBZROQVTHLCDU-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | KPBZROQVTHLCDU-UHFFFAOYSA-N |
Wikipedia | Clevidipine |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Clevidipine (links to external site)
Cat. No. HY-17436 |